InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
ORKA
Result 118 decisions over 120 months
Reset filters
Direction ?
Both118 Bought50 Sold68
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: ORKA
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
ORKA Oruka Therapeutics, Inc.
26 Feb 2018
BARRIS PETER J
10% owner indirect
Sold, plan not stated
1,460,209
$731.27K
100%
ORKA Oruka Therapeutics, Inc.
26 Feb 2018
Growth Equity Opportunities IV, LLC
10% owner
Sold, plan not stated
1,460,209
$731.27K
100%
ORKA Oruka Therapeutics, Inc.
14 Jul 2017
CONWAY ROBERT E
Director
Bought
10,000
$24.90K
40.0%
ORKA Oruka Therapeutics, Inc.
2 May 2017
MITCHELL DANIEL J
Director
Bought
11,000
$29.81K
opened
ORKA Oruka Therapeutics, Inc.
4 Apr 2017
BRISTOW MICHAEL R
Pres. & Chief Executive Offic
Sold, plan not stated
720
$1.74K
1.7%
ORKA Oruka Therapeutics, Inc.
4 Apr 2017
Ozeroff Christopher David
S.V.P., General Counsel
Sold, plan not stated
418
$1.01K
2.3%
ORKA Oruka Therapeutics, Inc.
4 Apr 2017
Keuer Thomas A
Chief Operating Officer
Sold, plan not stated
390
$939.90
2.7%
ORKA Oruka Therapeutics, Inc.
3 Apr 2017
Selby Brian L.
VP, Finance
Sold, plan not stated
1,114
$2.74K
46.6%
ORKA Oruka Therapeutics, Inc.
24 Mar 2017
CONWAY ROBERT E
Director
Bought
25,000
$64.75K
opened
ORKA Oruka Therapeutics, Inc.
28 Feb 2017
BRISTOW MICHAEL R
Pres. & Chief Executive Offic
Sold, plan not stated
763
$1.99K
1.8%
ORKA Oruka Therapeutics, Inc.
28 Feb 2017
Ozeroff Christopher David
S.V.P., General Counsel
Sold, plan not stated
465
$1.21K
2.5%
ORKA Oruka Therapeutics, Inc.
28 Feb 2017
Keuer Thomas A
Chief Operating Officer
Sold, plan not stated
465
$1.21K
3.1%
ORKA Oruka Therapeutics, Inc.
27 Feb 2017
Selby Brian L.
VP, Finance
Sold, plan not stated
161
$412.16
6.3%
ORKA Oruka Therapeutics, Inc.
18 Oct 2016
Keuer Thomas A
Chief Operating Officer
Sold, plan not stated
483
$1.18K
3.1%
ORKA Oruka Therapeutics, Inc.
20 Sep 2016
BRISTOW MICHAEL R
Pres. & Chief Executive Offic
Sold, plan not stated
1,972
$5.70K
4.4%
ORKA Oruka Therapeutics, Inc.
20 Sep 2016
Ozeroff Christopher David
S.V.P., General Counsel
Sold, plan not stated
1,185
$3.42K
6.1%
ORKA Oruka Therapeutics, Inc.
20 Sep 2016
Keuer Thomas A
Chief Operating Officer
Sold, plan not stated
714
$2.06K
4.4%
ORKA Oruka Therapeutics, Inc.
19 Sep 2016
Selby Brian L.
VP, Finance
Sold, plan not stated
476
$1.39K
15.7%
Showing 101–118 of 118. ← Newer Page 3 of 3